Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione and analogs

Authors:

Ivan Villax

Source:

GB 1397267

Pregnatrienedione I was prepd. from epoxypregnanetrione II in 7 steps. Thus, II underwent ketalization with HOCH2CH2OH, KBH4 redn., dehydration, Grignard reaction with MeMgBr, and deketalization to give pregnenedione III. III was treated with Br2-HOAc and then debrominated to I.

Also in the Knowledge Center

/ Jan 05, 2026

An integrated analytical approach to evaluate powder aggregation and predict the aerodynamic performance of homogeneous powders

Scientific Article

View

/ Mar 27, 2025

Pharmaceutical inhalation dry-powder sampling device, method and uses thereof

Scientific Article

View

/ Jun 06, 2025

A feeding system for a pharmaceutical processing system, a method for processing pharmaceutical components, a kit of parts for processing pharmaceutical components, and a system

Scientific Article

View

Browser not supported

Knowledge Center

16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione and analogs

Also in the Knowledge Center

An integrated analytical approach to evaluate powder aggregation and predict the aerodynamic performance of homogeneous powders

Pharmaceutical inhalation dry-powder sampling device, method and uses thereof

A feeding system for a pharmaceutical processing system, a method for processing pharmaceutical components, a kit of parts for processing pharmaceutical components, and a system

Related Content

Certificate of Suitability (CEP)

Continuous Tableting - Virtual Visit

Process Analytical Technology